Cortex

Internal developer portal for software teams

San Francisco, California, United States

About Cortex

Cortex provides an internal developer portal that aims to improve the efficiency and quality of software engineering. The platform offers tools for automatic cataloging of code, continuous assessment of software quality, and reliable deployment processes. It is designed specifically for software development teams, helping them manage and enhance their codebases more effectively. Unlike many competitors, Cortex emphasizes automation and ongoing improvement, which allows organizations to maintain high standards in their software development practices. The goal of Cortex is to help companies reduce their time-to-market and lower operational costs through its subscription-based services.

San Francisco, CaliforniaHeadquarters
2019Year Founded
$109.6MTotal Funding
SERIES_CCompany Stage
Enterprise SoftwareIndustries
51-200Employees

Benefits

Competitive pay & equity
Unlimited PTO
Cortex Wallet
Comprehensive health coverage
Retirement plans
Gender neutral parental leave
Weekly virtual team bonding experiences
Quarterly team retreats
Professional & career development

Risks

Increased competition from other internal developer portals may impact Cortex's market share.
Boston Scientific acquisition may lead to strategic shifts affecting Cortex's business model.
High valuation and funding may pressure Cortex for rapid growth, risking long-term stability.

Differentiation

Cortex offers a leading internal developer portal for enhanced engineering efficiency and quality.
The platform supports microservices and containerized development, providing a competitive edge.
Cortex integrates natively with GitLab, enhancing source code management for developers.

Upsides

Cortex raised $60 million in Series C funding for further development and expansion.
Recognition with the 2023 Technology Innovation Leadership Award boosts Cortex's industry reputation.
Acquisition by Boston Scientific could open new opportunities in healthcare technology.

Funding

Total raised$109.58 M
Latest valuation$470.00 M
StageSERIES_C